Insulin pump therapy, and more specifically insulin pump therapy combined continuous glucose monitors, provide the most intensive and precise therapy for people living with diabetes.  While costly to individuals who do not have private insurance, the savings in terms of improved productivity, increased availability for work, and improved health are immeasurable to society. Precise insulin dosing accompanied with real time monitorng of blood glucose levels can further decrease hospital visits and costly long term complications. Access to such medical devices should not be limited by age or income but should be available to all individuals who desire best health outcomes for themselves.